Ionis Pharmaceuticals (IONS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 160,079 | 145,537 | 133,367 | 493,680 | 167,892 |
| Cost of Goods | 3,086 | 3,012 | 2,548 | 1,012 | 967 |
| Gross Profit | 156,993 | 142,525 | 130,819 | 492,668 | 166,925 |
| Operating Expenses | 193,616 | 194,291 | 192,494 | 232,028 | 165,369 |
| Operating Income | -36,537 | -51,754 | -61,127 | 260,652 | 2,523 |
| Interest Expense | 2,428 | 2,441 | 2,207 | -22,963 | 12,002 |
| Other Income | 7,415 | 18,719 | 10,380 | -53,358 | 12,996 |
| Pre-tax Income | -31,550 | -35,476 | -52,954 | 230,257 | 3,517 |
| Income Tax | 5,064 | 2,084 | -3,072 | 42,302 | -14,915 |
| Net Income Continuous | -36,614 | -37,560 | -49,882 | 187,955 | 18,432 |
| Minority Interests | -12,147 | -11,924 | -10,254 | 19,542 | -7,731 |
| Net Income | $-24,467 | $-25,636 | $-39,628 | $168,413 | $26,163 |
| EPS Basic Total Ops | -0.18 | -0.18 | -0.28 | 1.19 | 0.19 |
| EPS Basic Continuous Ops | -0.26 | -0.27 | -0.36 | 1.34 | 0.13 |
| EPS Diluted Total Ops | -0.18 | -0.18 | -0.28 | 1.11 | 0.18 |
| EPS Diluted Continuous Ops | -0.26 | -0.27 | -0.36 | 1.18 | 0.13 |
| EBITDA(a) | $-27,254 | $-44,063 | $-55,306 | $239,058 | $13,880 |